Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Citigroup Inc. from $90.00 to $85.00. They now have a "neutral" rating on the stock.
Global DNA Sequencing Market Size Projected to Hit USD 52.1 Billion by 2032, Growing at a CAGR of 17.8% – SNS Insider [Yahoo! Finance]
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors [Yahoo! Finance]
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery